Thrombomodulin and its role in inflammation (original) (raw)

• Owen WG, Esmon CT (1981) Functional proerties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 256:5532–5535
  PubMed CAS Google Scholar
• Esmon CT, Owen WG (2004) The discovery of thrombomodulin. J Thromb Haemost 2:209–213
  PubMed CAS Google Scholar
• Ulutin ON, Seegers WH (1962) Autoprothrombin II and autoprothrombin II anticoagulant. Thromb Diath Haemorrh 7(Suppl):256–263
  PubMed CAS Google Scholar
• Esmon CT, Stenflo J, Suttie JW (1976) A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase. J Biol Chem 251:3052–3056
  PubMed CAS Google Scholar
• Stenflo J (1976) A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem 251:355–363
  PubMed CAS Google Scholar
• Kisiel W, Canfield WM, Ericsson EH, Davie EW (1977) Anticoagulant properties of bovine plasma protein C following activation of thrombin. Biochemistry 16:5824–5831
  PubMed CAS Google Scholar
• Salem HH, Maruyama I, Ishii H, Majerus PW (1984) Isolation and characterization of thrombomodulin from human placenta. J Biol Chem 259:12246–12251
  PubMed CAS Google Scholar
• Maruyama I, Bell C, Majerus P (1985) Thrombomodulin is found on endothelium of arteries, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol 101:363–371
  PubMed CAS Google Scholar
• Kawanami O, Jin E, Ghazizadeh M, Fujiwara M, Jiang L, Nagashima M et al (2000) Heterogeneous distribution of thrombomodulin and von Willebrand factor in endothelial cells in the human pulmonary microvessels. J Nippon Med Sch 67:118–125
  CAS Google Scholar
• Raife TJ, Lager DJ, Madison KC, Piette WW, Howard EJ, Sturm MT et al (1994) Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation. J Clin Invest 93:1846–1851
  PubMed CAS Google Scholar
• Conway E, Nowakowski B, Steiner-Mosonyi M (1992) Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation. Blood 80:1254–1263
  PubMed CAS Google Scholar
• Conway E, Nowakowski B (1993) Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis. Blood 81:726–733
  PubMed CAS Google Scholar
• McCachren SS, Diggs J, Weinberg JB, Dittman WA (1991) Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages. Blood 78:3128–3132
  PubMed CAS Google Scholar
• Soff GA, Jackman RW, Rosenberg RD (1991) Expression of thrombomodulin by smooth muscle cells in culture: different effects of tumor necrosis factor and cyclic adenosine monophosphate on thrombomodulin expression by endothelial cells and smooth muscle cells in culture. Blood 77:515–518
  PubMed CAS Google Scholar
• Boffa M-C, Burke B, Haudenschild C (1987) Preservation of thrombomodulin antigen on vascular and extravascular surfaces. J Histochem Cytochem 35:1267–1276
  PubMed CAS Google Scholar
• Boffa M, Jackman R, Peyri N, Boffa J, George B (1991) Thrombomodulin in the central nervous system. Nouv Rev Fr Hematol 33:423–429
  PubMed CAS Google Scholar
• Maillard C, Berruyer M, Serre CM, Amiral J, Dechavanne M, Delmas PD (1993) Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane. Endocrinology 133:668–674
  PubMed CAS Google Scholar
• Imada M, Imada S, Iwasaki H, Kume A, Yamaguchi H, Moore E (1987) Fetomodulin: marker surface protein of fetal development which is modulatable by cyclic AMP. Dev Biol 122:483–491
  PubMed CAS Google Scholar
• Imada S, Yamaguchi H, Nagumo M, Katayanagi S, Iwasaki H, Imada M (1990) Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays. Dev Biol 140:113–122
  PubMed CAS Google Scholar
• Wong V, Hofman FM, Ishii H, Fisher M (1991) Regional distribution of thrombomodulin in human brain. Brain Res 556:1–5
  PubMed CAS Google Scholar
• Tran ND, Wang L, Schreiber SS, Zlokovic B, Fisher M (1998) Measurement of thrombomodulin mRNA expression in brain capillaries by polymerase chain reaction [in process citation]. Thromb Res 91:191–197
  PubMed CAS Google Scholar
• Wang L, Tran N, Kittaka M, Fisher M, Schreiber S, Zlokovic B (1997) Thrombomodulin expression in bovine brain capillaries. Anticoagulant function of the blood–brain barrier, regional differences, and regulatory mechanisms. Arterioscler Thromb Vasc Biol 17:3139–3146
  PubMed CAS Google Scholar
• Jackson MT, Smith MM, Smith SM, Jackson CJ, Xue M, Little CB (2009) Activation of cartilage matrix metalloproteinases by activated protein C. Arthritis Rheum 60:780–791
  PubMed CAS Google Scholar
• Wang L, Bastarache JA, Wickersham N, Fang X, Matthay MA, Ware LB (2007) Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. Am J Respir Cell Mol Biol 36:497–503
  PubMed CAS Google Scholar
• Kawamura H, Hiramatsu Y, Watanabe I (1996) Localization of thrombomodulin in a rabbit eye. Curr Eye Res 15:938–942
  PubMed CAS Google Scholar
• Yerkovich ST, Roponen M, Smith ME, McKenna K, Bosco A, Subrata LS, et al (2009) Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a TH2-skewed immune response. J Allergy Clin Immunol 123:209.e4–216.e4.
  Google Scholar
• Isermann B, Hendrickson SB, Hutley K, Wing M, Weiler H (2001) Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block. Development 128:827–838
  PubMed CAS Google Scholar
• Isermann B, Sood R, Pawlinski R, Zogg M, Kalloway S, Degen JL et al (2003) The thrombomodulin–protein C system is essential for the maintenance of pregnancy. Nat Med 9:331–337
  PubMed CAS Google Scholar
• Boehme MW, Deng Y, Raeth U, Bierhaus A, Ziegler R, Stremmel W et al (1996) Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology 87:134–140
  PubMed CAS Google Scholar
• Lohi O, Urban S, Freeman M (2004) Diverse substrate recognition mechanisms for rhomboids: thrombomodulin is cleaved by mammalian rhomboids. Curr Biol 14:236–241
  PubMed CAS Google Scholar
• Yamamoto S, Mizoguchi T, Tamaki T, Ohkuchi M, Kimura S, Aoki N (1993) Urinary thrombomodulin, its isolation and characterization. J Biochem 113:433–440
  PubMed CAS Google Scholar
• Jackman RW, Beeler DL, Fritze L, Soff G, Rosenberg RD (1987) Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc Natl Acad Sci USA 84:6425–6429
  PubMed CAS Google Scholar
• Wen D, Dittman WA, Ye RD, Deaven LL, Majerus PW, Sadler JE (1987) Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene. Biochemistry 6:2960–2967
  Google Scholar
• Suzuki K, Kusomoto H, Deyashiki Y, Hishioka J, Maruyama I, Zushi M et al (1987) Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 6:1891–1897
  PubMed CAS Google Scholar
• Suzuki K, Deyashiki Y, Nishioka J, Kurachi K, Akira M, Yamamoto S et al (1987) Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily. J Biol Chem 262:611–616
  PubMed CAS Google Scholar
• Villoutreix B, Dahlback B (1998) Molecular model for the C-type lectin domain of human thrombomodulin. J Mol Model 4:310–322
  CAS Google Scholar
• Lu R, Esmon NL, Esmon CT, Johnson AE (1989) The active site of the thrombin–thrombomodulin complex. J Biol Chem 264:12956–12962
  PubMed CAS Google Scholar
• Weisel JW, Nagaswami C, Young TA, Light DR (1996) The shape of thrombomodulin and interactions with thrombin as determined by electron microscopy. J Biol Chem 271:31485–31490
  PubMed CAS Google Scholar
• Hamada H, Ishii H, Sakyo K, Horie S, Nishiki K, Kazama M (1995) The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for Swiss 3T3 cells. Blood 86:225–233
  PubMed CAS Google Scholar
• Tohda G, Oida K, Okada Y, Kosaka S, Okada E, Takahashi S et al (1998) Expression of thrombomodulin in atherosclerotic lesions and mitogenic activity of recombinant thrombomodulin in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 18:1861–1869
  PubMed CAS Google Scholar
• Kurosawa S, Stearns DJ, Jackson KW, Esmon CT (1988) A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site. J Biol Chem 263:5993–5996
  PubMed CAS Google Scholar
• Zushi M, Gomi K, Yamamoto S, Maruyama I, Hayashi T, Suzuki K (1989) The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem 264:10351–10353
  PubMed CAS Google Scholar
• Suzuki K, Hayashi T, Nishioka J, Kosaka Y, Zushi M, Honda G et al (1989) A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 264:4872–4876
  PubMed CAS Google Scholar
• Wang W, Nagashima M, Schneider M, Morser J, Nesheim M (2000) Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation. J Biol Chem 275:22942–22947
  PubMed CAS Google Scholar
• Schenk-Braat EA, Morser J, Rijken DC (2001) Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator. Eur J Biochem 268:5562–5569
  PubMed CAS Google Scholar
• Bourin MC, Lundgren ÅE, Lindahl U (1990) Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan. J Biol Chem 265:15424–15431
  PubMed CAS Google Scholar
• Conway E, Nowakowski B, Steiner-Mosonyi M (1994) Thrombomodulin lacking the cytoplasmic domain efficiently internalizes thrombin via nonclathrin-coated, pit-mediated endocytosis. J Cell Physiol 158:285–298
  PubMed CAS Google Scholar
• Conway EM, Pollefeyt S, Cornelissen J, DeBaere I, Steiner-Mosonyi M, Weitz JI et al (1999) Structure–function analyses of thrombomodulin by gene-targeting in mice: the cytoplasmic domain is not required for normal fetal development. Blood 93:3442–3450
  PubMed CAS Google Scholar
• Adler M, Seto MH, Nitecki DE, Lin JH, Light DR, Morser J (1995) The structure of a 19-residue fragment from the C-loop of the fourth epidermal growth factor-like domain of thrombomodulin. J Biol Chem 270:23366–23372
  PubMed CAS Google Scholar
• Wood MJ, Sampoli Benitez BA, Komives EA (2000) Solution structure of the smallest cofactor-active fragment of thrombomodulin. Nat Struct Biol 7:200–204
  PubMed CAS Google Scholar
• Fuentes-Prior P, Iwanaga Y, Huber R, Pagila R, Rumennik G, Seto M et al (2000) Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex [see comments]. Nature 404:518–525
  PubMed CAS Google Scholar
• Koeppe JR, Seitova A, Mather T, Komives EA (2005) Thrombomodulin tightens the thrombin active site loops to promote protein C activation. Biochemistry 44:14784–14791
  PubMed CAS Google Scholar
• Tsiang M, Lentz SR, Sadler JE (1992) Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity. J Biol Chem 267:6164–6170
  PubMed CAS Google Scholar
• Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L (1997) Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 78:386–391
  PubMed CAS Google Scholar
• Wu C, Kim PY, Manuel R, Seto M, Whitlow M, Nagashima M, Morser J, Gils A, Declerck P, Nesheim ME (2009) The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex. J Biol Chem 284:7059–7067
  Google Scholar
• Light DR, Glaser CB, Betts M, Blasko E, Campbell E, Clarke JH et al (1999) The interaction of thrombomodulin with Ca2+. Eur J Biochem 262:522–533
  PubMed CAS Google Scholar
• Adams TE, Huntington JA (2006) Thrombin–cofactor interactions: structural insights into regulatory mechanisms. Arterioscler Thromb Vasc Biol 26:1738–1745
  PubMed CAS Google Scholar
• Grinnell BW, Berg DT (1996) Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells. Am J Physiol 270:H603–H609
  PubMed CAS Google Scholar
• Lafay M, Laguna R, Le Bonniec BF, Lasne D, Aiach M, Rendu F (1998) Thrombomodulin modulates the mitogenic response to thrombin of human umbilical vein endothelial cells. Thromb Haemost 79:848–852
  PubMed CAS Google Scholar
• Esmon CT, Esmon NL, Harris KW (1982) Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 257:7944–7947
  PubMed CAS Google Scholar
• Esmon NL, Carroll RC, Esmon CT (1983) Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 258:12238–12242
  PubMed CAS Google Scholar
• Ye J, Esmon C, Johnson A (1993) The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin. J Biol Chem 268:2373–2379
  PubMed CAS Google Scholar
• Stenflo J, Fernlund P (1982) Amino acid sequence of the heavy chain of bovine protein C. J Biol Chem 257:12180–12190
  PubMed CAS Google Scholar
• Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT (1996) The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 93:10212–10216
  PubMed CAS Google Scholar
• Fukudome K, Ye X, Tsuneyoshi N, Tokunaga O, Sugawara K, Mizokami H et al (1998) Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor. J Exp Med 187:1029–1035
  PubMed CAS Google Scholar
• Laszik Z, Mitro A, Taylor FB Jr, Ferrell G, Esmon CT (1997) Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation 96:3633–3640
  PubMed CAS Google Scholar
• Fukudome K, Esmon C (1995) Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR). J Biol Chem 270:5571–5577
  PubMed CAS Google Scholar
• Dahlback B, Villoutreix BO (2005) Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure–function relationships and molecular recognition. Arterioscler Thromb Vasc Biol 25:1311–1320
  PubMed Google Scholar
• Slungaard A, Fernandez JA, Griffin JH, Key NS, Long JR, Piegors DJ et al (2003) Platelet factor 4 enhances generation of activated protein C in vitro and in vivo. Blood 102:146–151
  PubMed CAS Google Scholar
• Slungaard A (2005) Platelet factor 4: a chemokine enigma. Int J Biochem Cell Biol 37:1162–1167
  PubMed CAS Google Scholar
• Cooper ST, Rezaie AR, Esmon CT, Church FC (2002) Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II. Thromb Res 107:67–73
  PubMed CAS Google Scholar
• Yang L, Manithody C, Walston TD, Cooper ST, Rezaie AR (2003) Thrombomodulin enhances the reactivity of thrombin with protein C inhibitor by providing both a binding site for the serpin and allosterically modulating the activity of thrombin. J Biol Chem 278:37465–37470
  PubMed CAS Google Scholar
• Preissner KT, Delvos U, Muller-Berghaus G (1987) Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism. Biochemistry 26:2521–2528
  PubMed CAS Google Scholar
• Riewald M, Petrovan RJ, Donner A, Ruf W (2003) Activated protein C signals through the thrombin receptor PAR1 in endothelial cells. J Endotoxin Res 9:317–321
  PubMed CAS Google Scholar
• Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED et al (2003) Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9:338–342
  PubMed CAS Google Scholar
• Krupiczojc MA, Scotton CJ, Chambers RC (2008) Coagulation signalling following tissue injury: focus on the role of factor Xa. Int J Biochem Cell Biol 40:1228–1237
  PubMed CAS Google Scholar
• Levi M (2010) The coagulant response in sepsis and inflammation. Hämostaseologie 30(10–12):14–16
  Google Scholar
• Bajzar L, Manuel R, Nesheim M (1995) Purification and characterization of TAFI, a thrombin-activatable fibrinolysis inhibitor. J Biol Chem 270:14477–14484
  PubMed CAS Google Scholar
• Dai L, Mitchell M, Savidge G, Alhaq A (2004) The profibrinolytic effect of plasma thrombomodulin in factor XI deficiency and its implications in hemostasis. J Thromb Haemost 2:2200–2204
  PubMed CAS Google Scholar
• Nagashima M, Yin ZF, Broze GJ Jr, Morser J (2002) Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice. Front Biosci 7:d556–d568
  PubMed CAS Google Scholar
• Vercauteren E, Emmerechts J, Peeters M, Hoylaerts MF, Declerck PJ, Gils A (2011) Evaluation of the profibrinolytic properties of an anti-TAFI monoclonal antibody in a mouse thromboembolism model. Blood 117:4615–4622
  Google Scholar
• Campbell WD, Lazoura E, Okada N, Okada H (2002) Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol Immunol 46:131–134
  PubMed CAS Google Scholar
• Myles T, Nishimura T, Yun TH, Nagashima M, Morser J, Patterson AJ, et al (2003) Thrombin activatable fibrinolysis inhibitor: a potential regulator of vascular inflammation. J Biol Chem 278:51059–51067
  Google Scholar
• Morser J, Gabazza EC, Myles T, Leung LL (2010) What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse? J Thromb Haemost 8:868–876
  PubMed CAS Google Scholar
• Kokame K, Zheng X, Sadler J (1998) Activation of thrombin-activatable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C. J Biol Chem 273:12135–12139
  PubMed CAS Google Scholar
• Glaser C, Morser J, Clarke J, Blasko E, McLean K, Kuhn I et al (1992) Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. J Clin Invest 90:2565–2573
  PubMed CAS Google Scholar
• Wood MJ, Becvar LA, Prieto JH, Melacini G, Komives EA (2003) NMR structures reveal how oxidation inactivates thrombomodulin. Biochemistry 42:11932–11942
  PubMed CAS Google Scholar
• Wood MJ, Helena Prieto J, Komives EA (2005) Structural and functional consequences of methionine oxidation in thrombomodulin. Biochim Biophys Acta 1703:141–147
  PubMed CAS Google Scholar
• Adams GN, Larusch GA, Stavrou E, Zhou Y, Nieman MT, Jacobs GH et al (2011) Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis. Blood 117:3929–3937
  PubMed CAS Google Scholar
• Mosnier LO (2011) Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin. J Biol Chem 286:502–510
  PubMed CAS Google Scholar
• DeMunk G, Groeneveld E, Rijken DC (1991) Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (Pro-urokinase) by thrombomodulin. J Clin Invest 88:1680–1684
  CAS Google Scholar
• Molinari A, Giorgetti C, Lansen J, Vaghi F, Orsini G, Faioni E et al (1992) Thrombomodulin is a cofactor for thrombin degradation of recombinant single-chain urokinase plasminogen activator “in vitro” and in a perfused rabbit heart model. Thromb Haemost 67:226–232
  PubMed CAS Google Scholar
• Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B et al (2010) Molecular intercommunication between the complement and coagulation systems. J Immunol 185:5628–5636
  PubMed CAS Google Scholar
• Fu X, Parks WC, Heinecke JW (2008) Activation and silencing of matrix metalloproteinases. Semin Cell Dev Biol 19:2–13
  PubMed CAS Google Scholar
• Moore KL, Esmon CT, Esmon NL (1989) Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73:159–165
  PubMed CAS Google Scholar
• Maruyama I, Majerus PW (1985) The turnover of thrombin–thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. J Biol Chem 260:15432–15438
  PubMed CAS Google Scholar
• Beretz A, Freysinnet J-M, Gauchy J, Schmitt DA, Klein-Soyer C, Edgell C-JS et al (1989) Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926. Biochem J 259:35–40
  PubMed CAS Google Scholar
• Brisson C, Archipoff G, Harrmann M-L, Hanau D, Beretz A, Freyssinet J-M et al (1993) Antibodies to thrombomodulin induce receptor-mediated endocytosis in human saphenous vein endothelial cells. Thromb Haemost 68:737–743
  Google Scholar
• Hirokawa K, Aoki N (1991) Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. J Cell Physiol 147:157–165
  PubMed CAS Google Scholar
• Hirokawa K, Aoki N (1990) Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro. J Biochem (Tokyo) 108:839–845
  CAS Google Scholar
• Maruyama I, Majerus P (1987) Protein C inhibits endocytosis of thrombin-thrombomodulin complexes in A549 lung cancer cells and human umbilical vein endothelial cells. Blood 69:1481–1484
  PubMed CAS Google Scholar
• Conway E, Boffa M, Nowakowski B, Steiner-Mosonyi M (1992) An ultrastructural study of thrombomodulin endocytosis: internalization occurs via clathrin-coated and non-coated pits. J Cell Physiol 151:604–612
  PubMed CAS Google Scholar
• Tazawa T, Hirosawa S, Suzuki K, Hirokawa K, Aoki N (1993) Functional characterization of the 5′-regulatory region of the human thrombomodulin gene. J Biochem (Tokyo) 113:600–606
  CAS Google Scholar
• Yu K, Morioka H, Fritze L, Beeler D, Jackman R, Rosenberg R (1992) Transcriptional regulation of the thrombomodulin gene. J Biol Chem 267:23237–23247
  PubMed CAS Google Scholar
• Niforas P, Sanderson G, Bird C, Bird P (1993) Characterization of the mouse thrombomodulin gene and functional analysis of the 5′ flanking region in F9 teratocarcinoma cells. Biochim Biophys Acta 1173:179–188
  PubMed CAS Google Scholar
• Malek AM, Jackman R, Rosenberg RD, Izumo S (1994) Endothelial expression of thrombomodulin is reversibly regulated by fluid shear stress. Circ Res 74:852–860
  PubMed CAS Google Scholar
• Ohji T, Urano H, Shirahata A, Yamagishi M, Higashi K, Gotoh S et al (1995) Transforming growth factor beta1 and beta2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thromb Haemost 73:812–818
  PubMed CAS Google Scholar
• Ishii H, Tezuka T, Ishikawa H, Takada K, Oida K, Horie S (2003) Oxidized phospholipids in oxidized low-density lipoprotein down-regulate thrombomodulin transcription in vascular endothelial cells through a decrease in the binding of RARbeta–RXRalpha heterodimers and Sp1 and Sp3 to their binding sequences in the TM promoter. Blood 101:4765–4774
  PubMed CAS Google Scholar
• Rong Y, Zhang M, Zhang L, Wang XL, Shen YH (2010) JNK-ATF-2 inhibits thrombomodulin (TM) expression by recruiting histone deacetylase4 (HDAC4) and forming a transcriptional repression complex in the TM promoter. FEBS Lett 584:852–858
  PubMed CAS Google Scholar
• Sandusky G, Berg DT, Richardson MA, Myers L, Grinnell BW (2002) Modulation of thrombomodulin-dependent activation of human protein C through differential expression of endothelial Smads. J Biol Chem 277:49815–49819
  PubMed CAS Google Scholar
• Nan B, Yang H, Yan S, Lin PH, Lumsden AB, Yao Q et al (2005) C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Surgery 138:212–222
  PubMed Google Scholar
• Grey ST, Csizmadia V, Hancock WW (1998) Differential effect of tumor necrosis factor-alpha on thrombomodulin gene expression by human monocytoid (THP-1) cell versus endothelial cells [in process citation]. Int J Hematol 67:53–62
  PubMed CAS Google Scholar
• Kim HK, Kim JE, Chung J, Kim YT, Kang SH, Han KS et al (2007) Lipopolysaccharide down-regulates the thrombomodulin expression of peripheral blood monocytes: effect of serum on thrombomodulin expression in the THP-1 monocytic cell line. Blood Coagul Fibrinol 18:157–164
  CAS Google Scholar
• Conway EM, Rosenberg RD (1988) Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 8:5588–5592
  PubMed CAS Google Scholar
• Starr ME, Ueda J, Takahashi H, Weiler H, Esmon CT, Evers BM et al (2010) Age-dependent vulnerability to endotoxemia is associated with reduction of anticoagulant factors activated protein C and thrombomodulin. Blood 115:4886–4893
  PubMed CAS Google Scholar
• Sohn RH, Deming CB, Johns DC, Champion HC, Bian C, Gardner K et al (2005) Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood 105:3910–3917
  PubMed CAS Google Scholar
• Baeuerle PA (1998) IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 95:729–731
  PubMed CAS Google Scholar
• Hamaguchi E, Takamura T, Shimizu A, Nagai Y (2003) Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. J Pharmacol Exp Ther 307:987–994
  PubMed CAS Google Scholar
• Parry GC, Mackman N (1995) Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol 15:612–621
  PubMed CAS Google Scholar
• Conway EM, Carmeliet P (2004) The diversity of endothelial cells: a challenge for therapeutic angiogenesis. Genome Biol 5:207
  PubMed Google Scholar
• Welch W (1993) Heat shock proteins functioning as molecular chaperones: their roles in normal and stressed cells. Phil Trans R Soc Lond 339:327–333
  CAS Google Scholar
• Morimoto R (1993) Cells in stress: transcriptional activation of heat shock genes. Science 259:1409–1410.
  Google Scholar
• Udelsman R, Blake M, Stagg C, Li D, Putney D, Holbrook N (1993) Vascular heat shock protein expression in response to stress. J Clin Invest 91:465–473
  PubMed CAS Google Scholar
• Bielecka-Dabrowa A, Barylski M, Mikhailidis DP, Rysz J, Banach M (2009) HSP 70 and atherosclerosis—protector or activator? Expert Opin Ther Targets 13:307–317
  PubMed CAS Google Scholar
• Conway E, Liu L, Nowakowski B, Steiner-Mosonyi M, Jackman R (1994) Heat shock of vascular endothelial cells induces an upregulatory transcriptional response of the thrombomodulin gene that is delayed in onset and does not attenuate. J Biol Chem 269:22804–22810
  PubMed CAS Google Scholar
• Drake T, Cheng J, Chang A, Taylor F (1993) Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Path 142:1458–1470
  PubMed CAS Google Scholar
• Nawroth P, Stern D (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163:740–745
  PubMed CAS Google Scholar
• Laszik Z, Carson CW, Nadasdy T, Johnson LD, Lerner MR, Brackett DJ et al (1994) Lack of suppressed renal thrombomodulin expression in a septic rat model with glomerular thrombotic microangiopathy. Lab Invest 70:862–867
  PubMed CAS Google Scholar
• Wong HR, Ryan M, Wispe JR (1997) Stress response decreases NF-kappaB nuclear translocation and increases I-kappaBalpha expression in A549 cells. J Clin Invest 99:2423–2428
  PubMed CAS Google Scholar
• Calnek DS, Grinnell BW (1998) Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor. Exp Cell Res 238:294–298
  PubMed CAS Google Scholar
• Dittman WA, Kumada T, Majerus PW (1989) Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin. Proc Natl Acad Sci USA 86:7179–7182
  PubMed CAS Google Scholar
• Maruyama I, Soejima Y, Osame M, Ito T, Ogawa K, Yamamoto S et al (1991) Increased expression of thrombomodulin on the cultured human umbilical vein endothelial cells and mouse hemangioma cells by cyclic AMP. Thromb Res 61:301–310
  PubMed CAS Google Scholar
• Weiler GH, Yu K, Soff G, Gudas LJ, Rosenberg RD (1992) Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells. Proc Natl Acad Sci USA 89:2155–2159
  Google Scholar
• Shi J, Wang J, Zheng H, Ling W, Joseph J, Li D et al (2003) Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul Fibrinol 14:575–585
  CAS Google Scholar
• Rees DA, Giles P, Lewis MD, Ham J (2010) Adenosine regulates thrombomodulin and endothelial protein C receptor expression in folliculostellate cells of the pituitary gland. Purinergic Signal 6:19–29
  PubMed CAS Google Scholar
• Lentz SR, Sadler JE (1991) Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 88:1906–1914
  PubMed CAS Google Scholar
• Abe H, Okajima K, Okabe H, Takatsuki K, Binder BR (1994) Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro. J Lab Clin Med 123:874–881
  PubMed CAS Google Scholar
• Redl H, Schlag G, Schiesser A, Davies J (1995) Thrombomodulin release in baboon sepsis: its dependence on the dose of Escherichia coli and the presence of tumor necrosis factor. J Infect Dis 171:1522–1527
  PubMed CAS Google Scholar
• Inomata M, Ishihara Y, Matsuyama T, Imamura T, Maruyama I, Noguchi T et al (2009) Degradation of vascular endothelial thrombomodulin by arginine- and lysine-specific cysteine proteases from Porphyromonas gingivalis. J Periodontol 80:1511–1517
  PubMed CAS Google Scholar
• Glusa E (1992) Vascular effects of thrombin. Sem Thromb Hemost 18:296–304
  CAS Google Scholar
• Bizios R, Lai L, Fenton JW 2nd, Malik AB (1986) Thrombin-induced chemotaxis and aggregation of neutrophils. J Cell Physiol 128:485–490
  PubMed CAS Google Scholar
• Kudhal K, Fisker S, Sonne O (1991) A thrombin receptor in resident rat peritoneal macrophages. Exp Cell Res 193:45–53
  Google Scholar
• Naldini A, Bernini C, Pucci A, Carraro F (2005) Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes. J Leukoc Biol 78:736–744
  PubMed CAS Google Scholar
• Naldini A, Carney DH, Bocci V, Klimpel KD, Asuncion M, Soares LE et al (1993) Thrombin enhances T cell proliferative responses and cytokine production. Cell Immunol 147:367–377
  PubMed CAS Google Scholar
• Naldini A, Carney DH, Pucci A, Carraro F (2002) Human alpha-thrombin stimulates proliferation of interferon-gamma differentiated, growth-arrested U937 cells, overcoming differentiation-related changes in expression of p21CIP1/WAF1 and cyclin D1. J Cell Physiol 191:290–297
  PubMed CAS Google Scholar
• Naldini A, Carney DH, Pucci A, Pasquali A, Carraro F (2000) Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1. Gen Pharmacol 35:255–259
  PubMed CAS Google Scholar
• Naldini A, Pucci A, Carney DH, Fanetti G, Carraro F (2002) Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1. Cytokine 20:191–199
  PubMed CAS Google Scholar
• Chen L, Teng N, Buchanan J (1976) Mitogenicity of thrombin and surface alterations on mouse splenocytes. Exp Cell Res 101:41–46
  PubMed CAS Google Scholar
• Bar-Shavit R, Kahn AJ, Mann KG, Wilner GD (1986) Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci USA 83:976–980
  PubMed CAS Google Scholar
• Bar-Shavit R, Hruska K, Kahn A, Wilner G (1986) Hormone-like activity of human thrombin. Ann NY Acad Sci 485:335–348
  PubMed CAS Google Scholar
• Tatakis D, Dolce C, Dziak R (1989) Thrombin’s effects on osteoblastic cells. I. Cytosolic calcium and phosphoinositides. Biochem Biophys Res Commun 164:119–127
  PubMed CAS Google Scholar
• Furmaniak-Kazmierczak E, Cooke T, Manuel R, Scudamore A, Hoogendorn H, Giles A et al (1994) Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage. J Clin Invest 94:472–480
  PubMed CAS Google Scholar
• Tang H, Low B, Rutherford SA, Hao Q (2005) Thrombin induces endocytosis of endoglin and type-II TGF-beta receptor and down-regulation of TGF-beta signaling in endothelial cells. Blood 105:1977–1985
  PubMed CAS Google Scholar
• Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057–1068
  PubMed CAS Google Scholar
• Woolkalis M, DeMelfi TJ, Blanchard N, Hoxie J, Brass L (1995) Regulation of thrombin receptors on human umbilical vein endothelial cells. J Biol Chem 270:9868–9875.
  Google Scholar
• Minami T, Sugiyama A, Wu SQ, Abid R, Kodama T, Aird WC (2004) Thrombin and phenotypic modulation of the endothelium. Arterioscler Thromb Vasc Biol 24:41–53
  PubMed CAS Google Scholar
• Coughlin SR, Camerer E (2003) PARticipation in inflammation. J Clin Invest 111:25–27
  PubMed CAS Google Scholar
• Trejo J (2003) Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking. J Pharmacol Exp Ther 307:437–442
  PubMed CAS Google Scholar
• Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N et al (2005) Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26:1–43
  PubMed CAS Google Scholar
• Bhattacharya A, Cohen ML (2000) Vascular contraction and relaxation to thrombin and trypsin: thrombomodulin preferentially attenuates thrombin-induced contraction. J Pharmacol Exp Ther 295:284–290
  PubMed CAS Google Scholar
• Olivot JM, Estebanell E, Lafay M, Brohard B, Aiach M, Rendu F (2001) Thrombomodulin prolongs thrombin-induced extracellular signal-regulated kinase phosphorylation and nuclear retention in endothelial cells. Circ Res 88:681–687
  PubMed CAS Google Scholar
• Dufilho M, Millanvoye-Van Brussel E, Topal G, Walch L, Brunet A, Rendu F (2005) Endothelial thrombomodulin induces Ca2+ signals and no synthesis through epidermal growth factor receptor kinase and calmodulin kinase II. J Biol Chem 280:35999–36006
  Google Scholar
• Taylor FJ, Chang A, Esmon CT, Hinshaw LB (1991) Baboon model of Escherichia coli sepsis: description of its four stages and the role of tumor necrosis factor, tissue factors, and the protein C system in septic shock. Curr Stud Hematol Blood Transfus 58:8–14
  PubMed CAS Google Scholar
• Taylor F, Stearns-Kurosawa D, Kurosawa S, Ferrell G, Chang A, Laszik Z et al (2000) The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95(5):1680–1686
  PubMed CAS Google Scholar
• Hancock WW, Sayegh MH, Sablinski T, Kut JP, Kupiec-Weglinski JW, Milford EL (1992) Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy. Transplantation 53:1276–1280
  PubMed CAS Google Scholar
• Hirose K, Okajima K, Taoka Y, Uchiba M, Tagami H, Nakano K et al (2000) Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg 232:272–280
  PubMed CAS Google Scholar
• Mizutani A, Okajima K, Uchiba M, Noguchi T (2000) Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95:3781–3787
  PubMed CAS Google Scholar
• Levi M, Choi G, Schoots I, Schultz M, Van Der Poll T (2004) Beyond sepsis: activated protein C and ischemia–reperfusion injury. Crit Care Med 32:S309–312
  PubMed CAS Google Scholar
• Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW (1994) Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol 153:3664–3672
  PubMed CAS Google Scholar
• Brueckmann M, Hoffmann U, Dvortsak E, Lang S, Kaden JJ, Borggrefe M et al (2004) Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis. Inflamm Res 53:528–533
  PubMed CAS Google Scholar
• Levi M, Dorffler-Melly J, Reitsma P, Buller H, Florquin S, van der Poll T et al (2003) Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. Blood 101:4823–4827
  PubMed CAS Google Scholar
• Ganopolsky JG, Castellino FJ (2004) A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model. Am J Pathol 165:1433–1446
  PubMed CAS Google Scholar
• Weiler-Guettler H, Christie P, Beeler D, Healy A, Hancock W, Rayburn H et al (1998) A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest 101:1–9
  Google Scholar
• Weiler H, Lindner V, Kerlin B, Isermann B, Hendrickson S, Cooley B et al (2001) Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol 21:1531–1537
  PubMed CAS Google Scholar
• Rijneveld AW, Weijer S, Florquin S, Esmon CT, Meijers JC, Speelman P, et al (2003) Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 103:1702–1709
  Google Scholar
• Dahlback B (2003) The discovery of activated protein C resistance. J Thromb Haemost 1:3–9
  PubMed CAS Google Scholar
• Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64–67
  PubMed CAS Google Scholar
• Kerlin BA, Yan SB, Isermann BH, Brandt JT, Sood R, Basson BR et al (2003) Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood 102:3085–3092
  PubMed CAS Google Scholar
• Weiler H, Kerlin B, Lytle MC (2004) Factor V Leiden polymorphism modifies sepsis outcome: evidence from animal studies. Crit Care Med 32:S233–238
  PubMed CAS Google Scholar
• Oganesyan V, Oganesyan N, Terzyan S, Qu D, Dauter Z, Esmon NL et al (2002) The crystal structure of the endothelial protein C receptor and a bound phospholipid. J Biol Chem 277:24851–24854
  PubMed CAS Google Scholar
• Esmon CT (2004) Structure and functions of the endothelial cell protein C receptor. Crit Care Med 32:S298–S301
  PubMed CAS Google Scholar
• Kurosawa S, Stearns-Kurosawa DJ, Hidari N, Esmon CT (1997) Identification of functional endothelial protein C receptor in human plasma. J Clin Invest 100:411–418
  PubMed CAS Google Scholar
• Kurosawa S, Stearns-Kurosawa DJ, Carson CW, D’Angelo A, Della Valle P, Esmon CT (1998) Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 91:725–727
  PubMed CAS Google Scholar
• Xu J, Qu D, Esmon NL, Esmon CT (2000) Metalloproteolytic release of endothelial cell protein C receptor. J Biol Chem 275:6038–6044
  PubMed CAS Google Scholar
• Kurosawa S, Esmon CT, Stearns-Kurosawa DJ (2000) The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. J Immunol 165:4697–4703
  PubMed CAS Google Scholar
• Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296:1880–1882.
  Google Scholar
• Feistritzer C, Riewald M (2005) Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105:3178–3184
  PubMed CAS Google Scholar
• Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato T, Natori Y et al (2002) Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int 61:490–501
  PubMed CAS Google Scholar
• Koyama T, Parkinson JF, Aoki N, Bang NU, Müller BG, Preissner KT (1991) Relationship between post-translational glycosylation and anticoagulant function of secretable recombinant mutants of human thrombomodulin. Br J Haematol 78:515–522
  PubMed CAS Google Scholar
• Bourin MC, Lindahl U (1990) Functional role of the polysaccharide component of rabbit thrombomodulin proteoglycan. Effects on inactivation of thrombin by antithrombin, cleavage of fibrinogen by thrombin and thrombin-catalysed activation of Factor V. Biochem J 270:419–425
  PubMed CAS Google Scholar
• Rabhi-Sabile S, Steiner-Mosonyi M, Pollefeyt S, Collen D, Pouvelle B, Gysin J et al (1999) Plasmodium falciparum-infected erythrocytes: a mutational analysis of cytoadherence via murine thrombomodulin. Thromb Haemost 81:815–821
  PubMed CAS Google Scholar
• Warrell D, Molyneux M, Beales P (1990) Severe and complicated malaria. Trans R Soc Trop Med Hyg 84:1–65
  Google Scholar
• Rogerson SJ (2003) Sequestration: causes and consequences. Redox Rep 8:295–299
  PubMed CAS Google Scholar
• Gitau EN, Newton CR (2005) Review article: blood–brain barrier in falciparum malaria. Trop Med Int Health 10:285–292
  PubMed CAS Google Scholar
• Fried M, Duffy P (1996) Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272:1502–1504.
  Google Scholar
• Fried M, Duffy P (1998) Maternal malaria and parasite adhesion. J Mol Med 76:162–171
  PubMed CAS Google Scholar
• Pouvelle B, Meyer P, Robert C, Bardel L, Gysin J (1997) Chondroitin-4-sulfate impairs in vitro and in vivo cytoadherence of Plasmodium falciparum infected erythrocytes. Mol Med 3:508–518
  PubMed CAS Google Scholar
• Beeson JG, Chai W, Rogerson SJ, Lawson AM, Brown GV (1998) Inhibition of binding of malaria-infected erythrocytes by a tetradecasaccharide fraction from chondroitin sulfate A. Infect Immun 66:3397–3402
  PubMed CAS Google Scholar
• Edano T, Kumai N, Mizoguchi T, Ohkuchi M (1998) The glycosylation sites and structural characteristics of oligosaccharides on recombinant human thrombomodulin. Int J Biochem Cell Biol 30:77–88
  PubMed CAS Google Scholar
• Lin J-H, McLean K, Morser J, Young T, Wydro R, Andrews W et al (1994) Modulation of glycosaminoglycan addition in naturally expressed and recombinant human thrombomodulin. J Biol Chem 269:25021–25030
  PubMed CAS Google Scholar
• Gerlitz B, Hassell T, Vlahos CJ, Parkinson JF, Bang NU, Grinnell BW (1993) Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474. Biochem J 295:131–140
  PubMed CAS Google Scholar
• Pouvelle B, Fusai T, Gysin J (1998) Revue generale. Plasmodium falciparum et chondroitin-4-sulfate: Le nouveau couple cle de al sequestration. Med Trop 58:187–198.
  Google Scholar
• Pruna A, Peyri N, Berard M, Boffa M-C (1997) Thrombomodulin is synthesized by human mesangial cells. Kidney Int 51:687–693
  PubMed CAS Google Scholar
• Salanti A, Dahlback M, Turner L, Nielsen MA, Barfod L, Magistrado P et al (2004) Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 200:1197–1203
  PubMed CAS Google Scholar
• Dodd RB, Drickamer K (2001) Lectin-like proteins in model organisms: implications for evolution of carbohydrate-binding activity. Glycobiology 11:71R–79R
  PubMed CAS Google Scholar
• Vasta GR, Quesenberry M, Ahmed H, O’Leary N (1999) C-type lectins and galectins mediate innate and adaptive immune functions: their roles in the complement activation pathway. Dev Comp Immunol 23:401–420
  PubMed CAS Google Scholar
• Drickamer K (1988) Two distinct classes of carbohydrate-recognition domains in animal lectins. J Biol Chem 263:9557–9560
  PubMed CAS Google Scholar
• Sim RB, Tsiftsoglou SA (2004) Proteases of the complement system. Biochem Soc Trans 32:21–27
  PubMed CAS Google Scholar
• Petersen T (1988) The amino-terminal domain of thrombomodulin and pancreatic stone protein are homologous with lectins. FEBS Lett 231:51–53
  PubMed CAS Google Scholar
• Patthy L (1988) Detecting distant homologies of mosaic proteins. Analysis of the sequences of thrombomodulin, thrombospondin, complement components C9, C8 alpha and C8 beta, vitronectin and plasma cell membrane glycoprotein PC-1. J Mol Biol 202:689–696
  PubMed CAS Google Scholar
• Opavsky R, Haviernik P, Jurkovicova D, Garin MT, Copeland NG, Gilbert DJ et al (2001) Molecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo. J Biol Chem 276:38795–38807
  PubMed CAS Google Scholar
• MacFadyen JR, Haworth O, Roberston D, Hardie D, Webster MT, Morris HR et al (2005) Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett 579:2569–2575
  PubMed CAS Google Scholar
• McGreal E, Gasque P (2002) Structure–function studies of the receptors for complement C1q. Biochem Soc Trans 30:1010–1014
  PubMed CAS Google Scholar
• Greenlee MC, Sullivan SA, Bohlson SS (2008) CD93 and related family members: their role in innate immunity. Curr Drug Targets 9:130–138
  PubMed CAS Google Scholar
• Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A et al (2002) The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med 196:565–577
  PubMed CAS Google Scholar
• Geudens N, Van de Wouwer M, Vanaudenaerde BM, Vos R, Van De Wauwer C, Verleden GM et al (2008) The lectin-like domain of thrombomodulin protects against ischaemia–reperfusion lung injury. Eur Respir J 32:862–870
  PubMed CAS Google Scholar
• Van de Wouwer M, Plaisance S, DeVries A, Waelkens E, Collen D, Persson J et al (2006) The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. J Thromb Haemost 4:1813–1824
  PubMed Google Scholar
• Abeyama K, Stern DM, Ito Y, Kawahara KI, Yoshimoto Y, Tanaka M, et al (2005) The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 115:1267–1274
  Google Scholar
• Alleva LM, Yang H, Tracey KJ, Clark IA (2005) High mobility group box 1 (HMGB1) protein: possible amplification signal in the pathogenesis of falciparum malaria. Trans R Soc Trop Med Hyg 99:171–174
  PubMed CAS Google Scholar
• Chen G, Li J, Qiang X, Czura CJ, Ochani M, Ochani K et al (2005) Suppression of HMGB1 release by stearoyl lysophosphatidylcholine: an additional mechanism for its therapeutic effects in experimental sepsis. J Lipid Res 46:623–627
  PubMed CAS Google Scholar
• Yang H, Wang H, Czura CJ, Tracey KJ (2005) The cytokine activity of HMGB1. J Leukoc Biol 78:1–8
  PubMed CAS Google Scholar
• Mun-Bryce S, Rosenberg G (1998) Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab 18:1163–1172
  PubMed CAS Google Scholar
• Schmidt AM, Yan SD, Yan SF, Stern DM (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 1498:99–111
  PubMed CAS Google Scholar
• Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331–342
  PubMed CAS Google Scholar
• Ito T, Kawahara K, Okamoto K, Yamada S, Yasuda M, Imaizumi H et al (2008) Proteolytic cleavage of high mobility group box 1 protein by thrombin–thrombomodulin complexes. Arterioscler Thromb Vasc Biol 28:1825–1830
  PubMed CAS Google Scholar
• Esmon C (2005) Do-all receptor takes on coagulation, inflammation. Nat Med 11:475–477
  PubMed CAS Google Scholar
• Huang HC, Shi GY, Jiang SJ, Shi CS, Wu CM, Yang HY, et al (2003) Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. J Biol Chem 278:46750–46759
  Google Scholar
• Shi CS, Shi GY, Hsiao SM, Kao YC, Kuo KL, Ma CY et al (2008) Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood 112:3661–3670
  PubMed CAS Google Scholar
• Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G et al (2009) Thrombomodulin mutations in atypical hemolytic–uremic syndrome. New Engl J Med 361:345–357
  PubMed CAS Google Scholar
• Busso N, Morard C, Salvi R, Peclat V, So A (2003) Role of the tissue factor pathway in synovial inflammation. Arthritis Rheum 48:651–659
  PubMed CAS Google Scholar
• Nakano S, Ikata T, Kinoshita I, Kanematsu J, Yasuoka S (1999) Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 17:161–170
  PubMed CAS Google Scholar
• Yang YH, Hall P, Little CB, Fosang AJ, Milenkovski G, Santos L et al (2005) Reduction of arthritis severity in protease-activated receptor-deficient mice. Arthritis Rheum 52:1325–1332
  PubMed CAS Google Scholar
• Li J, Ny A, Leonardsson G, Nandakumar KS, Holmdahl R, Ny T (2005) The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis. Am J Pathol 166:783–792
  PubMed CAS Google Scholar
• Judex MO, Mueller BM (2005) Plasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more. Am J Pathol 166:645–647
  PubMed Google Scholar
• So AK, Varisco PA, Kemkes-Matthes B, Herkenne-Morard C, Chobaz-Peclat V, Gerster JC et al (2003) Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 1:2510–2515
  PubMed CAS Google Scholar
• Pekovich SR, Bock PE, Hoover RL (2001) Thrombin–thrombomodulin activation of protein C facilitates the activation of progelatinase A. FEBS Lett 494:129–132
  PubMed CAS Google Scholar
• Buisson-Legendre N, Smith S, March L, Jackson C (2004) Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2. Arthritis Rheum 50:2151–2156
  PubMed CAS Google Scholar
• Laszik ZG, Zhou XJ, Ferrell GL, Silva FG, Esmon CT (2001) Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. Am J Pathol 159:797–802
  PubMed CAS Google Scholar
• Mathew M, Tay E, Cusi K (2010) Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc Diabetol 9:9
  PubMed Google Scholar
• Soskic SS, Dobutovic BD, Sudar EM, Obradovic MM, Nikolic DM, Zaric BL, et al (2011) The peroxisome proliferator-activated receptors and atherosclerosis. Angiology [Epub ahead of print]
• Mangan S, Clancy P, Golledge J (2008) Modulation of endothelial cell thrombomodulin by PPAR ligands—variation according to environment. Thromb Res 121:827–834
  PubMed CAS Google Scholar
• Reriani MK, Dunlay SM, Gupta B, West CP, Rihal CS, Lerman LO, et al. Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials. Eur J Cardiovasc Prev Rehabil. 2011.
• Lin SJ, Hsieh FY, Chen YH, Lin CC, Kuan II, Wang SH et al (2009) Atorvastatin induces thrombomodulin expression in the aorta of cholesterol-fed rabbits and in TNFalpha-treated human aortic endothelial cells. Histol Histopathol 24:1147–1159
  PubMed CAS Google Scholar
• Rossi J, Rouleau L, Tardif JC, Leask RL (2010) Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress. Life Sci 87:92–99
  PubMed CAS Google Scholar
• Masamura K, Oida K, Kanehara H, Suzuki J, Horie S, Ishii H et al (2003) Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family. Arterioscler Thromb Vasc Biol 23:512–517
  PubMed CAS Google Scholar
• Manthey HD, Thomas AC, Shiels IA, Zernecke A, Woodruff TM, Rolfe B, et al (2011) Complement C5a inhibition reduces atherosclerosis in ApoE−/− mice. FASEB J 25:2447–2455
  Google Scholar
• Speidl WS, Kastl SP, Huber K, Wojta J (2011) Complement in atherosclerosis: friend or foe? J Thromb Haemost 9:428–440
  PubMed CAS Google Scholar
• Yamaji K, Wang Y, Liu Y, Abeyama K, Hashiguchi T, Uchimura T et al (2005) Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation. Thromb Res 115:319–325
  PubMed CAS Google Scholar
• Zorio E, Navarro S, Medina P, Estelles A, Osa A, Rueda J et al (2006) Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions. J Thromb Haemost 4:1530–1536
  PubMed CAS Google Scholar
• Boffa MC, Karmochkine M (1998) Thrombomodulin: an overview and potential implications in vascular disorders. Lupus 7:S120–125
  PubMed CAS Google Scholar
• Lin SM, Wang YM, Lin HC, Lee KY, Huang CD, Liu CY et al (2008) Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis. Crit Care Med 36:683–689
  PubMed CAS Google Scholar
• Matondo Maya DW, Mewono L, Nkoma AM, Issifou S, Mavoungou E (2008) Markers of vascular endothelial cell damage and P. falciparum malaria: association between levels of both sE-selectin and thrombomodulin, and cytokines, hemoglobin and clinical presentation. Eur Cytokine Netw 19:123–130
  PubMed Google Scholar
• Salomaa V, Matei C, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H et al (1999) Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case–cohort study. Lancet 353:1729–1734
  PubMed CAS Google Scholar
• Wu KK (2003) Soluble thrombomodulin and coronary heart disease. Curr Opin Lipidol 14:373–375
  PubMed CAS Google Scholar
• Wu KK, Aleksic N, Ballantyne CM, Ahn C, Juneja H, Boerwinkle E (2003) Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease. Circulation 107:1729–1732
  PubMed CAS Google Scholar
• Ohlin A-K, Marlar R (1995) The first mutation identified in the thrombomodulin gene in a 45 year old man presenting with thromboembolic disease. Blood 85:330–336
  PubMed CAS Google Scholar
• Kunz G, Ohlin AK, Adami A, Zoller B, Svensson P, Lane DA (2002) Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function. Blood 99:3646–3653
  PubMed CAS Google Scholar
• Konstantoulas CJ, Cooper J, Warnock G, Miller GJ, Humphries SE, Ireland H (2004) A combination of two common thrombomodulin gene variants (−1208–1209TTdelTT and A455V) influence risk of coronary heart disease: a prospective study in men. Atherosclerosis 177:97–104
  PubMed CAS Google Scholar
• Doggen CJ, Kunz G, Rosendaal FR, Lane DA, Vos HL, Stubbs PJ et al (1998) A mutation in the thrombomodulin gene, 127G to A coding for Ala25Thr, and the risk of myocardial infarction in men. Thromb Haemost 80:743–748
  PubMed CAS Google Scholar
• Waugh JM, Yuksel E, Li J, Kuo MD, Kattash M, Saxena R et al (1999) Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model. Circ Res 84:84–92
  PubMed CAS Google Scholar
• Mohri M, Oka M, Aoki Y, Gonda Y, Hirata S, Gomi K et al (1994) Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats. Am J Hematol 45:298–303
  PubMed CAS Google Scholar
• Gonda Y, Hirata S, Saitoh K, Aoki Y, Mohri M, Gomi K et al (1993) Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Thromb Res 71:325–335
  PubMed CAS Google Scholar
• Uchiba M, Okajima K, Murakami K, Nawa K, Okabe H, Takatsuki K (1995) Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats. Thromb Haemost 74:1265–1270
  PubMed CAS Google Scholar
• Iba T, Nakarai E, Takayama T, Nakajima K, Sasaoka T, Ohno Y (2009) Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model. Crit Care 13:R203.
  Google Scholar
• Taoka Y, Okajima K, Uchiba M, Johno M (2000) Neuroprotection by recombinant thrombomodulin. Thromb Haemost 83:462–468
  PubMed CAS Google Scholar
• Kaneko H, Joubara N, Yoshino M, Yamazaki K, Mitumaru A, Miki Y et al (2000) Protective effect of human urinary thrombomodulin on ischemia–reperfusion injury in the canine liver. Eur Surg Res 32:87–93
  PubMed CAS Google Scholar
• Ozaki T, Anas C, Maruyama S, Yamamoto T, Yasuda K, Morita Y et al (2008) Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Nephrol Dial Transplant 23:110–119
  PubMed CAS Google Scholar
• Sharfuddin AA, Sandoval RM, Berg DT, McDougal GE, Campos SB, Phillips CL et al (2009) Soluble thrombomodulin protects ischemic kidneys. J Am Soc Nephrol 20:524–534
  PubMed CAS Google Scholar
• Hagiwara S, Iwasaka H, Goto K, Ochi Y, Mizunaga S, Saikawa T, et al (2010) Recombinant thrombomodulin prevents heat stroke by inhibition of high mobility group box 1 protein in sera of rats. Shock 34:402–406
  Google Scholar
• Sperling C, Salchert K, Streller U, Werner C (2004) Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro. Biomaterials 25:5101–5113
  PubMed CAS Google Scholar
• Moll S, Lindley C, Pescatore S, Morrison D, Tsuruta K, Mohri M et al (2004) Phase I study of a novel recombinant human soluble thrombomodulin, ART-123. J Thromb Haemost 2:1745–1751
  PubMed CAS Google Scholar
• Kearon C, Comp P, Douketis J, Royds R, Yamada K, Gent M (2005) Dose–response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost 3:962–968
  PubMed CAS Google Scholar
• Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R et al (2007) Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 5:31–41
  PubMed CAS Google Scholar
• Levi M (2010) Japanese consensus for disseminated intravascular coagulation (DIC): is it a small world after all? Thromb Res 125:4–5
  PubMed CAS Google Scholar
• Takagi T, Taguchi O, Toda M, Ruiz DB, Bernabe PG, D’Alessandro-Gabazza CN, et al (2011) Inhibition of allergic bronchial asthma by thrombomodulin is mediated by dendritic cells. Am J Respir Crit Care Med 183:31–42
  Google Scholar